Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06232603 · ClinicalTrials.gov registry record · NA
Medication Adherence Intervention in Chronic Recurrent Multifocal Osteomyelitis (CRMO)
A NA study, sponsored by Seattle Children's Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT06232603 is a NA study that was terminated before completion, run by Seattle Children's Hospital. The registered enrollment target is 9 participants.
The verdict
NCT06232603, a NA study, was terminated before completion, sponsored by Seattle Children's Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This project aims to quantify and evaluate rates of non-adherence and barriers to medication adherence in pediatric patients with CRMO followed at Seattle Children's Hospital's robust CRMO program, which is the only clinical program in the Washington, Wyoming, Alaska, Montana, Idaho (WWAMI) region. This will be a stepped-wedge cluster-randomized trial, in which participants will be randomly assigned to one of two groups -- one which receives educational materials at the end of their first clinic visit, and the other which receives educational materials at the end of their second clinic visit. All participants will be given baseline surveys at the start of their first clinic visit, as well as follow-up surveys at the start of their second and third clinic visits. These surveys aim to evaluate rates of non-adherence and qualitative barriers to adherence, as well as efficacy of educational interventions in improving adherence rates.
Interventions
- OTHER Education of medication management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2024-02-20 |
| Est. Completion | 2024-06-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06232603
The ClinicalTrials.gov registry entry for NCT06232603 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Education of medication management is the first listed.
NCT06232603 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06232603 about?
NCT06232603 is a clinical study titled "Medication Adherence Intervention in Chronic Recurrent Multifocal Osteomyelitis (CRMO)". This project aims to quantify and evaluate rates of non-adherence and barriers to medication adherence in pediatric patients with CRMO followed at Seattle Children's Hospital's robust CRMO program, which is the only clinical program in the Washington, Wyoming, Alaska, Montana, Idaho (WWAMI) region. ...
What is the current status of trial NCT06232603?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2024-02-20. Estimated completion is 2024-06-18.
What interventions are being tested in trial NCT06232603?
The interventions under investigation include: Education of medication management (OTHER).
Who is sponsoring clinical trial NCT06232603?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.